Kanamycin and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Kanamycin (kanamycin sulfate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Olmesartan Medoxomil, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Weakness when taking Kanamycin. It is created by eHealthMe based on reports of 931 people who have side effects when taking Kanamycin from the FDA, and is updated regularly.

What is Kanamycin?

Kanamycin has active ingredients of kanamycin sulfate. eHealthMe is studying from 934 Kanamycin users. Check the latest studies of Kanamycin.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 02, 2026

931 people reported to have side effects when taking Kanamycin.
Among them, 21 people (2.26%) have Weakness.

Among these 21 people:

How long have people been on Kanamycin when they have Weakness? *

What is the gender of people who have Weakness when taking Kanamycin? *

female: 45 %
male: 55 %

What is the age of people who have Weakness when taking Kanamycin? *

What are other drugs people take besides Kanamycin? *

Allopurinol: 3 people, 14.29%
Furosemide: 3 people, 14.29%
Amoxicillin And Clavulanate Potassium: 3 people, 14.29%
Heparin: 3 people, 14.29%
Pyridoxine: 3 people, 14.29%
Olmesartan Medoxomil: 3 people, 14.29%
Omeprazole: 2 people, 9.52%
Heparin Sodium: 2 people, 9.52%
Humalog: 2 people, 9.52%
Vimpat: 2 people, 9.52%

What are other side effects people have besides Weakness? *

General Physical Health Deterioration (weak health status): 6 people, 28.57%
Nausea (feeling of having an urge to vomit): 6 people, 28.57%
Death: 5 people, 23.81%
Nausea And Vomiting: 5 people, 23.81%
Sopor (sleep): 5 people, 23.81%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 19.05%
Emotional Distress: 4 people, 19.05%
Acute Kidney Failure: 4 people, 19.05%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 19.05%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 14.29%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 8 people, 38.10%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 5 people, 23.81%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 3 people, 14.29%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 9.52%
Diabetes: 2 people, 9.52%
Diarrhea: 2 people, 9.52%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 9.52%
Hiv Infection: 2 people, 9.52%
Vulvovaginal Candidiasis (vulvovaginal infection by fungi): 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Kanamycin and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kanamycin:

Kanamycin (934 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Kanamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on kanamycin sulfate (the active ingredients of Kanamycin) and Kanamycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.